The FDA rejected linvoseltamab, Regeneron’s experimental antibody for multiple myeloma, the company announced Wednesday morning.
In an earnings call earlier this …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening disability one to two years later, according to
As many as 40,000 people in the drug manufacturing industry arrived in Barcelona this week for the annual Convention of Pharmaceutical Ingredients (CPHI), which is
Eli Lilly’s tirzepatide is officially entering the market for chronic weight management. The drugmaker said Wednesday that the GIP/GLP-1 receptor agonist, which is known as